PATENT CLAIM ANALYSIS

Application Number: 15868582
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "650000"]

Abstract:
The present invention relates to methods of treating overactive bladder and the symptoms associated therewith, for example, urinary urgency, frequency of micturitions, nocturia, and urgency urinary incontinence. One treatment method according to the present invention comprises treatment with the beta-3 adrenergic receptor agonist solabegron. Another treatment combination according to the invention comprises solabegron, and a muscarinic receptor antagonist which results in a synergistic effect on the symptoms associated with OAB.

Claim (Index 12):
The method of  claim 7 , further comprising alleviating one or more of the symptoms of overactive bladder selected from the group consisting of urinary urgency, nocturia, and urgency urinary incontinence, or a combination thereof.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.64583
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15323685', '13762563', '13196068', '10817332', '10863770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7599538746412915
- 35 USC 102 Novelty (BERT): 0.6581868145906616
- Combined Prediction Score: 0.7497771686362285
- Mean Citation Score: 429.207076
- Max Citation Score: 620.9333
- Similarity Product: 616.2471404103459

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test